Trial Site Detail
Drug: |
XL820 |
|||
|---|---|---|---|---|
Trial: |
Study of XL820 Given Orally Daily to Subjects With Solid Tumors |
|||
| Conditions: | Cancer | |||
Trial Status: |
Completed |
|||
Cancer Therapy and Research Center7979 Wurzbach Rd. |
Principal Investigator: |
Alain C. Mita, MD |
|---|---|
Contact: |
Pat O'Rourke 210-616-5976 porourke@idd.org |
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
Cancer Therapy and Research Center Website: |
http://www.ctrc.net/research/clinicalname.cfm |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.